Chronic active Epstein-Barr virus infection with dilatation of the Valsalva sinus

Pediatrics International

Volumn 48, Issue 6, 2006, Pages 643-645

  Sato, Yuya ^a   Tsuboi, Tatsuo ^a   Mikami, Tetsuya ^a   Kurosawa, Hidemitsu ^a   Kanou, Kenichi ^a   Sugita, Kenichi ^a   Kimura, Hiroshi ^b   Nagasaka, Tetsuro ^b   Imashyuku, Shinsaku ^c   Eguchi, Mitsuoki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Kyoto City Institute of Health and Environmental Sciences   (Japan)

Author keywords

Chronic active Epstein Barr virus; Leukemia; Valsalva sinus

Indexed keywords

DEXAMETHASONE; PREDNISOLONE; VIRUS DNA;

AORTA SINUS; AORTA SINUS ANEURYSM; ARTICLE; CASE REPORT; CHRONIC DISEASE; CHRONIC GLOMERULONEPHRITIS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; VIRUS INFECTION;

AORTIC ANEURYSM; CHILD; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FEMALE; HUMANS; SINUS OF VALSALVA;

EID: 33751356030     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2006.02283.x     Document Type: Article

References (10)

1. Kawa K. Epstein-Barr virus-associated diseases in humans. Int. J. Hematol. 2000; 71: 108-17.
2. Kasahara Y, Yachie A, Takei K et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001; 98: 1882-8.
3. Zhang Y, Nagata H, Ikeuchi T et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br. J. Haematol. 2003; 121: 805-14.
4. Nakagawa A, Ito M, Iwaki T, Yatabe Y, Asai J, Hayashi K. Chronic active Epstein-Barr virus infection with giant coronary aneurysms. Am. J. Clin. Pathol. 1996; 105: 733-6.
5. Fujiwara M, Shimozono H, Ono H et al. Polyclonal proliferation of lymphocytes containing the epstein-barr virus genome in a patient dying of myocarditis in chronic active Epstein-Barr virus infection. J. Pediatr. Hematol. Oncol. 2003; 25: 85-8.
6. Yamamoto M, Kimura H, Hironaka T et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J. Clin. Microbiol. 1995; 33: 1765-8.
7. Kimura H, Morishima T, Kanegane H et al. Japanese Association for Research on Epstein-Barr Virus and Related Diseases. Prognostic factors for chronic active Epstein-Barr virus infection . J. Infect. Dis. 2003; 187: 527-33.
8. Henter JI, Samuelsson-Horne A, Arico M et al. Histocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-73.
9. Shirasaki F, Taniuchi K, Matsushita T, Hamaguhi Y, Takata M, Takehara K. Epstein-Barr virus-associated T-cell lymphoma: a case of eyelid swelling and intramuscular infiltration mimicking dermatomyositis. Br. J. Dermatol. 2002; 147: 1244-8.
10. Okada H, Ikeda N, Kobayashi T et al. An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis. Nephron 2002; 92: 440-44.